Home > D. Systemic pathology > Genetic and developmental anomalies > Genetic metabolic diseases > adult polyglucosan body disease

adult polyglucosan body disease

MIM.263570

Tuesday 3 January 2006

Adult polyglucosan body disease is a late-onset, slowly progressive, autosomal recessive disorder affecting the central and peripheral nervous systems. Patients typically present after age 40 years with a variable combination of cognitive impairment, pyramidal tetraparesis, peripheral neuropathy, and neurogenic bladder. Other manifestations include cerebellar dysfunction and extrapyramidal signs. THis disease is an allelic disorder to type IV glycogen storage disease with GBE1 mutations (MIM.232500).

Synopsis

- widespread accumulation of round, intracellular polyglucosan bodies throughout the nervous system, which are confined to neuronal and astrocytic processes.
- neurogenic bladder
- micturition difficulties
- gait disturbance
- upper motor neuron signs
- pyramidal tetraparesis
- cognitive impairment
- white matter abnormalities (MRI)
- polyglucosan bodies (round intracellular inclusions) found in neuronal and astrocytic processes
- peripheral neuropathy
- distal sensory impairment
- paresthesias
- Onset after age 40 years
- Slowly progressive disease

Etiology

- adult polyglucosan body disease is caused by germline mutation in the glycogen branching enzyme gene GBE1 (MIM.607839).

  • Mutation in the same gene GBE1 causes type IV glycogen storage disease (GSD IV) (MIM.232500), an early childhood disorder with systemic manifestations.
  • Decreased or absent glycogen branching enzyme activity